Patents by Inventor Birgit Alberta Louisa Maria Deiman

Birgit Alberta Louisa Maria Deiman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8298761
    Abstract: The present invention is related to a pair of oligonucleotide primers for the amplification of HSV nucleic acid comprising: a) an oligonucleotide, 10-50 nucleotides in length, preferably 10-35 nucleotides in length, comprising at least a fragment of 10 nucleotides of a sequence selected from the group consisting of: 5?-ACGTTCACCAAGCTGCTGCT-3?, or its complementary sequence and b) an oligonucleotide, 10-50 nucleotides in length, preferably 10-35 nucleotides in length, comprising at least a fragment of 10 nucleotides of a sequence selected from the group consisting of: 5?CCAGGGCCCTGGAGGTGCGG-3?, or its complementary sequence. The invention also relates to probes, method for amplifying an HSV DNA target, method of specific ou aspecific detection of HSV type 1 and 2 and test kit to do possible the detection of HSV. The present invention is especially useful in methods for practicing nucleic acid test.
    Type: Grant
    Filed: November 17, 2005
    Date of Patent: October 30, 2012
    Assignee: Biomerieux B.V.
    Inventors: Birgit Alberta Louisa Maria Deiman, Saskia Vermeer-Van Der Laar
  • Patent number: 7794986
    Abstract: The invention relates to a method for amplification of a target RNA sequence, wherein the first primer comprises a hybridizing sequence of 7 to 14 nucleotides, which is capable of binding to a first segment of the target RNA sequence, a transcription enhancing sequence, and an anchor which is capable of binding to a second segment of the target RNA sequence, and/or wherein the second primer comprises a hybridizing sequence of 7 to 14 nucleotides, an amplification enhancing sequence and an anchor which is capable of binding to a second segment of the first single stranded cDNA. The invention further relates to primers for the amplification of target RNA sequences and to a kit comprising one or more of the primers.
    Type: Grant
    Filed: October 27, 2004
    Date of Patent: September 14, 2010
    Assignee: Biomerieux B.V.
    Inventors: Birgit Alberta Louisa Maria Deiman, Arnoldina Margaretha Wilhelmina Strijp
  • Publication number: 20080280284
    Abstract: The present invention is related to a pair of oligonucleotide primers for the amplification of HSV nucleic acid comprising: a) an oligonucleotide, 10-50 nucleotides in length, preferably 10-35 nucleotides in length, comprising at least a fragment of 10 nucleotides of a sequence selected from the group consisting of: 5?-ACGTTCACCAAGCTGCTGCT-3?, or its complementary sequence and b) an oligonucleotide, 10-50 nucleotides in length, preferably 10-35 nucleotides in length, comprising at least a fragment of 10 nucleotides of a sequence selected from the group consisting of: 5?CCAGGGCCCTGGAGGTGCGG-3?, or its complementary sequence. The invention also relates to probes, method for amplifying an HSV DNA target, method of specific ou aspecific detection of HSV type 1 and 2 and test kit to do possible the detection of HSV. The present invention is especially useful in methods for practicing nucleic acid test.
    Type: Application
    Filed: November 17, 2005
    Publication date: November 13, 2008
    Inventors: Birgit Alberta Louisa Maria Deiman, Saskia Vermeer-Van Der Laar
  • Publication number: 20080241891
    Abstract: The present invention provides a method for the transcription based amplification of a target HBV nucleic acid sequence starting from HBV DNA optionally present in a sample, comprising the steps of, —incubating the sample, suspected to contain HBV, in an amplification buffer with one or more restriction enzymes capable of cleaving the HBV DNA at a selected restriction site, said restriction enzyme creating a defined 3? end of said HBV DNA stand(s), a promoter-primer, said promoter-primer having a 5? region comprising the sequence of a promoter recognized by a DNA-dependent RNA polymerase and a 3? region complementary to the define 3? end of the DNA strand, a second or reverse primer, having the opposite polarity of the promoter-primer and comprising the 5? end of the said target sequence, and in case of HBV ssDNA as the target sequence, a restriction primer, maintaining the thus created reaction mixture under the appropriate conditions for a sufficient amount of time for a digestion by the restriction enzyme
    Type: Application
    Filed: December 14, 2007
    Publication date: October 2, 2008
    Inventors: Birgit Alberta Louisa Maria Deiman, Inge Marjolein Frantzen, Arnoldina Margaretha Wilhelmina Van Strijp
  • Publication number: 20080176294
    Abstract: The invention relates to a method for amplification of a target RNA sequence, wherein the first primer comprises a hybridizing sequence of 7 to 14 nucleotides, which is capable of binding to a first segment of the target RNA sequence, a transcription enhancing sequence, and an anchor which is capable of binding to a second segment of the target RNA sequence, and/or wherein the second primer comprises a hybridizing sequence of 7 to 14 nucleotides, an amplification enhancing sequence and an anchor which is capable of binding to a second segment of the first single stranded cDNA. The invention further relates to primers for the amplification of target RNA sequences and to a kit comprising one or more of the primers.
    Type: Application
    Filed: October 27, 2004
    Publication date: July 24, 2008
    Applicant: BIOMERIEUX B.V.
    Inventors: Birgit Alberta Louisa Maria Deiman, Arnoldina Margaretha Wilhelmina Strijp
  • Publication number: 20040152090
    Abstract: The present invention is directed to a transcription based amplification method for the amplification of DNA targets starting from ds or ssDNA optionally present in a sample, comprising the steps of:—incubating the sample in an amplification buffer with one or more restriction enzymes capable of cleaving DNA at a selected restriction site, said restriction enzyme creating a defined 3′ end on the said DNA strand(s), and a promoter-primer, said promoter-primer having a 5′ region comprising the sequence of a promoter recognized by a DNA-dependent RNA polymerase and a 3′ region complementary to the defined 3′ end of the DNA strand, a second primer, having the opposite polarity of the promoter-primer and comprising the 5′ end of the target sequence, and in case of ssDNA as the target DNA, a restriction primer;—maintaining the thus created reaction mixture under the appropriate conditions for a sufficient amount of time for a digestion by the restriction enzyme to take plac
    Type: Application
    Filed: March 23, 2004
    Publication date: August 5, 2004
    Inventors: Birgit Alberta Louisa Maria Deiman, Inge Marjolein Frantzen, Arnoldina Margaretha Wilhelmina Strijp